Evidence map›Paper›PMID 41457852›Full record

Observational studyCancer medicine2026

Quality of Life and Return to Work After Radiotherapy in Young Adults With Head-and-Neck Cancer-A Bicentric Cross-Sectional Observational Study.

Charlotte Pannenbecker, Clemens Seidel, Jiadai Zou, Daniel Schnell, Gunnar Wichmann, Christoph Becker, Sabine Klagges, Henning Schäfer, Andreas Knopf, Andreas Dietz and 4 more

Abstract readObservational StudyMulticenter Study
In one paragraph

Observational study in Cancer medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Charlotte PannenbeckerDepartment of Radiation Oncology, University Medical Center Leipzig, Leipzig, Germany.
Clemens SeidelDepartment of Radiation Oncology, University Medical Center Leipzig, Leipzig, Germany.
Jiadai ZouDepartment of Radiation Oncology, University Medical Center Leipzig, Leipzig, Germany.
Daniel SchnellDepartment of Radiation Oncology, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Gunnar WichmannComprehensive Cancer Center Central (CCCG) Germany, Partner Site Leipzig, Leipzig, Germany.ORCID https://orcid.org/0000-0001-6191-2095
Christoph BeckerDepartment of Otorhinolaryngology, Head and Neck Surgery, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Germany.
Sabine KlaggesClinical Cancer Registry Leipzig Region (CCRL), Leipzig, Germany.
Henning SchäferDepartment of Radiation Oncology, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Andreas KnopfDepartment of Otorhinolaryngology, Head and Neck Surgery, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Germany.
Andreas DietzComprehensive Cancer Center Central (CCCG) Germany, Partner Site Leipzig, Leipzig, Germany.
Anca-Ligia GrosuDepartment of Radiation Oncology, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Anja Mehnert-TheuerkaufComprehensive Cancer Center Central (CCCG) Germany, Partner Site Leipzig, Leipzig, Germany.ORCID https://orcid.org/0000-0002-6872-9805
Nils H NicolayDepartment of Radiation Oncology, University Medical Center Leipzig, Leipzig, Germany.
Alexander RühleDepartment of Radiation Oncology, University Medical Center Leipzig, Leipzig, Germany.ORCID https://orcid.org/0000-0003-2022-897X

Funding

Roland Ernst Stiftung
6 · The paper itself

Abstract

objectiveYoung adults (18-45 years) with head-and-neck cancer represent a unique population with limited data on quality of life (QoL) and return-to-work after radiotherapy. This bicentric study aimed to evaluate these outcomes.

methodsConducted at two comprehensive cancer centers, the study included young head-and-neck cancer survivors treated with curative radiotherapy between 2003 and 2023. QoL was assessed with EORTC QLQ-C30 and HN43; distress, depression, and anxiety with the NCCN Distress Thermometer, PHQ-9, and GAD-7; fear of cancer progression and work ability with FoP-Q-SF and WAI.

resultsOut of 83 eligible patients, 58 (70%) participated. The median age at radiotherapy was 41 years, with a balanced gender distribution (40% female, 60% male). The median time from radiotherapy to questionnaire completion was 82.5 months. Mean global QoL was 65.0, comparable to the age- and gender-matched reference population (67.2). Clinically relevant distress was reported by 52%, severe depressive symptoms by 12%, moderate-to-severe anxiety by 21%, and strong fear of cancer progression by 38%. At the time of the study, 66% had returned to work. Those who returned to work reported lower symptom scores, and less depression, anxiety, and distress. In the multiple regression analysis, gender was significantly associated with return to work, with females showing higher odds of returning.

conclusionsWhile overall QoL was comparable to the general population, young head-and-neck cancer survivors face psychological and work reintegration challenges. Returning to work is associated with improved QoL and reduced psychological symptoms, highlighting the need for tailored survivorship care.

Indexed as

Cancer SurvivorsHead and Neck NeoplasmsQuality of LifeReturn to WorkAdolescentAdultAnxietyCross-Sectional StudiesDepressionFemaleHumansMaleMiddle AgedSurveys and QuestionnairesYoung AdultAYAchemotherapyhead‐and‐neck cancerpatient‐reported outcomespsycho‐oncologyquality‐of‐life, radiotherapy, return‐to‐work

Identifiers

PMID41457852
PMCPMC12745888

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.